IPL 2021: Wanindu Hasaranga and Dushmantha Chameera have left the IPL bio-bubble to sign up for the Sri Lankan squad for its T20 International Cup qualifiers marketing campaign.

IPL 2021: RCB unencumber Wanindu Hasaranga, Dushmantha Chameera from bio-bubble (PTI Photograph)


  • Hasaranga and Chameera were launched from the RCB bio bubble
  • Hasaranga and Chameera will sign up for Sri Lankan squad for T20 International Cup qualifiers
  • Sri Lanka will play first Qualifer fit of T20 International Cup on October 18

Royal Challengers Bangalore on Monday introduced that the franchise has launched the Sri Lankan duo- Wanindu Hasaranga and Dushmantha Chameera- to ensure that them to sign up for the SL squad for its T20 International Cup qualifiers marketing campaign beginning on the finish of this week.

Each Hasaranga and Chameera had been roped in through the Virat Kohli-led RCB forward of the UAE leg of the IPL 2021, with the previous taking part in two fits for the facet. Chameera, alternatively, didn’t get a possibility to play for RCB.

“Wanindu Hasaranga & Dushmantha Chameera have been released from the RCB bio bubble as they join up with the SL team for their #WT20 qualifiers. We wish both of them the best & thank them for their professionalism & hard work during #IPL2021,” RCB tweeted.

In the meantime, Sri Lanka Cricket (SLC) has introduced the overall 15-man squad for the approaching ICC T20 International Cup 2021 which starts on October 17 within the United Arab Emirates (UAE) and Oman. Sri Lanka and 7 different groups are positioned within the qualifying spherical probably the most fits.

Sri Lanka is in Crew A of spherical one fits which additionally has Eire, Namibia, and the Netherlands. Sri Lanka will face Namibia on October 18 in Abu Dhabi. Sri Lanka will tackle Eire on October 20, additionally in Abu Dhabi, and final they’ll face the Netherlands on October 22 in Sharjah. The highest two ranked groups will then continue to the Tremendous 12s spherical.

Click on right here for IndiaToday.in’s complete coverage of the coronavirus pandemic.

Source link


Please enter your comment!
Please enter your name here